DEMUSTIN 100 MG

País: Israel

Língua: inglês

Origem: Ministry of Health

Ingredientes ativos:

BENDAMUSTINE HYDROCHLORIDE

Disponível em:

RAFA LABORATORIES LTD

Código ATC:

L01AA09

Forma farmacêutica:

POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION

Composição:

BENDAMUSTINE HYDROCHLORIDE 100 MG/VIAL

Via de administração:

I.V

Tipo de prescrição:

Required

Fabricado por:

INTAS PHARMACEUTICALS LTD, INDIA

Área terapêutica:

BENDAMUSTINE

Indicações terapêuticas:

First-line treatment of chronic lymphocytic leukaemia (Binet stage B or C) in patients for whom fludarabine combination chemotherapy is not appropriate.Indolent non-Hodgkin’s lymphomas as monotherapy in patients, who have progressed during or within 6 months following treatment with rituximab or a rituximab containing regimen.Follicular non-Hodgkin’s lymphoma as first line treatment in combination with rituximab.

Data de autorização:

2017-11-28